The protein has a predicted molecular mass of 32.7 kDa after removal of the signal peptide. The apparent molecular mass of BAFF-R-hFc is approximately 35-55 kDa due to glycosylation.

Konjugat

Unconjugated

Reinheit

> 95%, by SDS-PAGE and Coomassie blue staining.

Produktform

Lyophilized

Konzentration

Reconstitution dependent.

Formulierung

Lyophilized from sterile Phosphate Buffered Saline, pH 7.4. Normally 5%–8% Trehalose is added as a protectant before lyophilization.

Lagerung

Shipped at 4°C. Lyophilized: Store at -20°C to -80°C. Reconstituted: Aliquot and store at -80°C. Product is stable for one year. Avoid freeze/thaw cycles.

Synonyme

B cell activating factor receptor, B-cell-activating factor receptor, BAFF R, BAFF Receptor, BAFFR, BLyS receptor 3, BlySR3, BR 3, BR3, BROMIX, CD 268, CD268, CD268 antigen, CVID4, MGC138235, OTTHUMP00000028746, Prolixin, TNFRSF 13C, Tnfrsf13c, TR13C_HUMAN, Tumor necrosis factor receptor subunit member 13C, Tumor necrosis factor receptor superfamily member 13C

Haftungsausschluss

Dieses Produkt ist nur für Forschungszwecke bestimmt. Es ist nicht für diagnostische oder therapeutische Zwecke bestimmt.

Produktbilder (2)

Bild Vergrößern

Figure 1: SDS-PAGE - Recombinant Human BAFF-R Protein (Fc Tag) (A318232)

Recombinant Human BAFF-R Protein (Fc Tag) (A318232) on SDS-PAGE under reducing conditions.

Bild Vergrößern

Figure 2: Recombinant Human BAFF-R Protein (Fc Tag) (A318232)

ELISA plates were pre-coated with 2 µg/ml (100 µl/well) Recombinant Human BAFF-R Protein (Fc Tag) (A318232) which can bind Anti-BAFF-R Antibody [Ianalumab Biosimilar] - Azide free (A318911) in a linear range of 3.2-80 µg/ml.